Trial Profile
Study Evaluating Rapid Infusion Rituximab in Patients With Autoimmune Diseases
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 27 Sep 2017
Price :
$35
*
At a glance
- Drugs Rituximab (Primary)
- Indications Autoimmune disorders; Multiple sclerosis
- Focus Adverse reactions
- 05 Aug 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 24 Feb 2014 New trial record